A research team from The Hong Kong University of Science and Technology (HKUST) has made an advance in understanding the molecular machinery of RNA silencing. The team uncovered how the human enzyme ...

RNA cancer vaccines have the potential to significantly boost the immune system’s ability to fight and eliminate tumors.

An Australian tech entrepreneur has helped create what appears to be a made-to-measure cancer vaccine for his dog, Rosie, using artificial ...

One dog, one vaccine, one data point. The story of Rosie is fascinating – but it is not yet evidence that AI can beat cancer.

Next Conyngham used Grok to design an mRNA vaccine that boosts the production of tumor-associated antigens enabling Rosie's ...

Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a malignancy that often develops in a chronically inflamed milieu . Here, tumour ...

A dedicated pet owner helped treat his dog's terminal cancer by running her tumor's genetic code through an AI chatbot, creating a vaccine just for her. 'Rose is my best mate and she's been with me ...

It will fund clinical trials of vaccines, which are therapeutic and often experimental, that activate the immune system to attack tumors.

Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting engineered particles can influence immune metabolism in ways that may ...

HHS plans 200M cancer vaccine initiative to fund public-private partnerships studying vaccines for high-risk cancer patients.

Acurastem received a grant to develop ALS therapies targeting SYF2, a regulator of TDP-43, in collaboration with academic research teams.